# Janssen Biotech, Inc. – FDA Inspection, Mar 5, 2018

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/4135886d-b271-492a-8b05-81d78eba721b
Source feed: FDA_Inspections

> FDA inspection 1046499 of Janssen Biotech, Inc., March 05, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046499
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2018-03-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/0ecc31ca-e799-4909-bfc9-dcdfa484fbf5)
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- [FDA Inspection 1031776 - 2017-11-21](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/2f697eb7-fa9a-4da8-b845-2d83b13b09f0)
- FDA Inspection 1027122 - 2017-09-22

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)

Company: https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c